Atlas Trials

Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

Clinical trial NCT05838560 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05838560
Sponsor
Washington University School of Medicine
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
SchizophreniaTreatment Resistant DepressionAging, Premature
Start date
2023-07-01
Primary completion
2027-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.